"Spot-scanning" proton therapy for rhabdomyosarcomas of early childhood. First experiences at PSI;Protonentherapie mit "spot-scanning" bei rhabdomyosarkomen im frühen kindesalter. Erste erfahrungen am PSI

Strahlentherapie und Onkologie

Volumn 182, Issue 11, 2006, Pages 653-659

  Timmermann, Beate ^a   Schuck, Andreas ^b   Niggli, Felix ^c   Weiss, Markus ^c   Lomax, Anthony ^a   Goitein, Gudrun ^a  

^a PAUL SCHERRER INSTITUTE   (Switzerland)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c Universitats Kinderklinik   (Switzerland)

Author keywords

Children; Irradiation; Protons; Soft tissue tumors

Indexed keywords

ARTICLE; BONE MARROW TOXICITY; CHILDHOOD DISEASE; CONTROLLED STUDY; FEASIBILITY STUDY; HEAD AND NECK TUMOR; HUMAN; ORBIT TUMOR; PARAMENINGEAL DISORDER; PHOTON THERAPY; PROSTATE TUMOR; RADIATION DOSE; RHABDOMYOSARCOMA; SEDATION; TOXICITY TESTING;

ADOLESCENT; AGE FACTORS; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MENINGEAL NEOPLASMS; ORBITAL NEOPLASMS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; PROTONS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RHABDOMYOSARCOMA; RHABDOMYOSARCOMA, ALVEOLAR; RHABDOMYOSARCOMA, EMBRYONAL; SOFT TISSUE NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33750489047     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-006-1592-y     Document Type: Article

References (32)

1. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-6.
2. DeLaney TF, Trofimov AV, Engelsman M, et al. Advanced-technology radiation therapy in the management of bone and soft tissue sarcomas. Cancer Control 2005;12:27-35.
3. Donaldson SS, Meza J, Breneman JC, et al. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma - a report from the IRSG. Int J Radiat Oncol Biol Phys 2001;51:718-28.
4. Flamant F, Rodary C, Rey A, et al. Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84. Eur J Cancer 1998;34:1050-62.
5. Hocht S, Stark R, Seiler F, et al. Proton or stereotactic photon irradiation for posterior uveal melanoma? A planning intercomparison. Strahlenther Onkol 2005;181:783-8.
6. Huang E, Teh BS, Strother DR, et al. Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity. Int J Radiat Oncol Biol Phys 2002;52:599-605.
7. Hug EB, Slater JD. Proton radiation therapy for pediatric malignancies: status report. Strahlenther Onkol 1999;175:Suppl 2:89-91.
8. Kaste SC, Hopkins KP, Bowman LC. Dental abnormalities in long-term survivors of head and neck rhabdomyosarcoma. Med Pediatr Oncol 1995;25:96-101.
9. Kony SJ, de Vathaire F, Chompret A, et al. Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood. Lancet 1997;350:91-5.
10. Kretzler A, Molls M, Gradinger R, et al. Intraoperative radiotherapy of soft tissue sarcoma of the extremity. Strahlenther Onkol 2004;180:365-70.
11. Kry SF, Salehpour M, Followill DS, et al. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2005;62:1195-203.
12. Lee CT, Bilton SD, Famiglietti RM, et al. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? Int J Radiat Oncol Biol Phys 2005;63:362-72.
13. Lomax A. Intensity modulation methods for proton radiotherapy. Phys Med Biol 1999;44:185-205.
14. Lomax AJ, Bohringer T, Bolsi A, et al. Treatment planning and verification of proton therapy using spot scanning: initial experiences. Med Phys 2004;31:3150-7.
15. Miralbell R, Cella L, Weber D, et al. Optimizing radiotherapy of orbital and paraorbital tumors: intensity-modulated X-ray beams vs. intensity-modulated proton beams. Int J Radiat Oncol Biol Phys 2000;47:1111-9.
16. Miralbell R, Lomax A, Cella L, et al. Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys 2002;54:824-9.
17. Mock U, Bogner J, Georg D, et al. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy. Strahlenther Onkol 2005;181:448-55.
18. Mock U, Georg D, Bogner J, et al. Treatment planning comparison of conventional, 3D conformal, and intensity-modulated photon (IMRT) and proton therapy for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys 2004;58:147-54.
19. Paulino AC. Late effects of radiotherapy for pediatric extremity sarcomas. Int J Radiat Oncol Biol Phys 2004;60:265-74.
20. Paulino AC, Simon JH, Zhen W, et al. Long-term effects in children treated with radiotherapy for head and neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 2000;48:1489-95.
21. Pedroni E, Scheib S, Bohringer T, et al. Experimental characterization and physical modelling of the dose distribution of scanned proton pencil beams. Phys Med Biol 2005;50:541-61.
22. Pinter AB, Hock A, Kajtar P, et al. Long-term follow-up of cancer in neonates and infants: a national survey of 142 patients. Pediatr Surg Int 2003;19:233-9.
23. Raney RB, Asmar L, Vassilopoulou-Sellin R, et al. Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: a descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and -III. IRS Group of the Children's Cancer Group and the Pediatric Oncology Group. Med Pediatr Oncol 1999;33:362-71.
24. Saran F. New technology for radiotherapy in paediatric oncology. Eur J Cancer 2004;40:2091-105.
25. Schuck A, Hamelmann V, Bramswig JH, et al. Ovarian function following pelvic irradiation in prepubertal and pubertal girls and young adult women. Strahlenther Onkol 2005;181:534-9.
26. Schuck A, Mattke AC, Schmidt B, et al. Group II rhabdomyosarcoma and rhabdomyosarcoma-like tumors: is radiotherapy necessary? J Clin Oncol 2004;22:143-9.
27. Spunt SL, Hill DA, Motosue AM, et al. Clinical features and outcome of initially unresected nonmetastatic pediatric nonrhabdomyosarcoma soft tissue sarcoma. J Clin Oncol 2002;20:3225-35.
28. St Clair WH, Adams JA, Bues M, et al. Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma. Int J Radiat Oncol Biol Phys 2004;58:727-34.
29. Stiller CA, Stevens MC, Magnani C, et al. Survival of children with soft-tissue sarcoma in Europe since 1978: results from the EUROCARE study. Eur J Cancer 2001;37:767-74.
30. Wharam MD, Hanfelt JJ, Tefft MC, et al. Radiation therapy for rhabdomyosarcoma: local failure risk for Clinical Group III patients on Intergroup Rhabdomyosarcoma Study II. Int J Radiat Oncol Biol Phys 1997;38:797-804.
31. Wolden SL, Wexler LH, Kraus DH, et al. Intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 2005;61:1432-8.
32. Yock T, Schneider R, Friedmann A, et al. Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photons. Int J Radiat Oncol Biol Phys 2005;63:1161-8.